Agregator de Jurnale Medicale de Specialitate

Agregator de Jurnale Medicale de Specialitate

Agregatorul de știri și noutăți prezintă cele mai noi studii clinice și noutăți despre tratamente medicale oncologice, tratamente de radioterapie și radiochirurgie, publicate în jurnalele medicale de specialitate la nivel internatțional:

Brivanib in combination with Notch3 silencing shows potent activity in tumour modelsBrivanib in combination with Notch3 silencing shows potent activity in tumour models, Published online: 15 February 2019; doi:10.1038/s41416-018-0375-4Brivanib in combination with Notch3 silencing shows potent activity in tumour models [...]
vin, Feb 15, 2019
Source: Jurnalul de Oncologie UK
HAI-2 as a novel inhibitor of plasmin represses lung cancer cell invasion and metastasisHAI-2 as a novel inhibitor of plasmin represses lung cancer cell invasion and metastasis, Published online: 15 February 2019; doi:10.1038/s41416-019-0400-2HAI-2 as a novel inhibitor of plasmin represses lung cancer cell invasion and metastasis [...]
vin, Feb 15, 2019
Source: Jurnalul de Oncologie UK
Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinomaIntegrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma, Published online: 15 February 2019; doi:10.1038/s41416-018-0373-6Integrated analysis [...]
vin, Feb 15, 2019
Source: Jurnalul de Oncologie UK
Synergistic antitumour activity of HDAC inhibitor SAHA and EGFR inhibitor gefitinib in head and neck cancer: a key role for ΔNp63αSynergistic antitumour activity of HDAC inhibitor SAHA and EGFR inhibitor gefitinib in head and neck cancer: a key role for ΔNp63α, Published online: 15 February 2019; doi:10.1038/s41416-019-0394-9Synergistic antitumour activity of [...]
vin, Feb 15, 2019
Source: Jurnalul de Oncologie UK
TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancerTYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer, Published online: 15 February 2019; doi:10.1038/s41416-019-0397-6TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer [...]
vin, Feb 15, 2019
Source: Jurnalul de Oncologie UK